Delivery Order SPE2DB20D1100-SPE2DB25FE1W6
- Not listed
- The Defense Logistics Agency awarded a $6,181.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 ml syringes (2 ml). The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-set-aside competitive procurement of this pharmaceutical product for delivery to the company's headquarters location in Conshohocken, Pennsylvania. EUFLEXXA is a hyaluronic acid-based injection used for knee osteoarthritis treatment,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes in 2 ml quantities. This is a firm fixed price delivery order with a ceiling value of $2,575.50 and an ultimate completion date of July 30, 2025. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. EUFLEXXA is a viscosupplementation...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Euflexxa 20 mg/2 ml syringes. The contract has a total ceiling value of $11,485.66 and a period of performance through May 23, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes with a ceiling value of $6,754.59 on August 14, 2025. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and no set-aside designation was used. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for joint pain treatment. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The award has a ceiling value of $6,113.56 and an ultimate completion date of September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML. The contract has a potential value of $8,961.84 and a completion date of March 7, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $3,108.48 firm fixed price contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical supply product. The contract has an ultimate completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical (valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,618.45, is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,474.82 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a completion date of September 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1W6Delivery Order
The Defense Logistics Agency awarded a $36,127.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 20, 2025, with completion targeted for August 21, 2025. Euflexxa is a hyaluronic acid-based injectable used for knee osteoarthritis pain management. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the vendor's broader federal contract portfolio with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves military and veteran healthcare systems through this comprehensive global pharmaceutical support vehicle, which enables the company to supply a vast range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The IDC structure allows DLA to issue delivery orders on an as-needed basis for pharmaceutical products supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.1k | 8/20/25 |